display
Amsterdam (AP) - The European Medicines Agency (EMA) plans to issue an opinion next week on possible thromboses from the corona vaccine from Johnson & Johnson.
The examination will be accelerated, the authority announced on Wednesday in Amsterdam.
Until the decision is made, the vaccine can continue to be used without restrictions.
The EMA continues to hold that the “benefits of the vaccine to prevent Covid-19” should be rated higher than the risks of side effects.
Last week, the EMA announced that it was investigating very rare cases of blood clots in cerebral veins after vaccinations.
So far, six cases have been reported to the EMA, mostly from the United States.
The US authorities suspended the use of the vaccine on Tuesday until a connection was clarified.
So far, around 6.8 million people in the United States have been vaccinated with it.
The vaccine is approved in the EU, but the first delivery had only arrived this week.
display
The US manufacturer is in close contact with the national authorities, the EMA announced.
He recommends that the EU states not use cans that have already been delivered for the time being.
© dpa-infocom, dpa: 210414-99-203933 / 2
Communication from the EMA